Mighty Therapeutics CEO Reenie McCarthy attended the RARE Drug Development Symposium hosted by Global Genes.

At Mighty Therapeutics (formerly named Stealth BioTherapeutics), our work is personal. We apply deep biological understanding and development expertise to advance novel therapies, and we have the tenacity to progress them from discovery to approval to broad patient access. We work with individuals living with mitochondrial disease and their families and healthcare providers to advance our shared goals of developing new therapies to improve care and quality of life. The voices of these individuals are mighty, and we hope to amplify and answer them. Together, we are working to expand what is possible for people living with the devasting effects of mitochondrial diseases. Please be aware of the potential for scams claiming to represent Mighty Therapeutics in recruitment activities. Mighty exclusively uses @mightytx.com e-mail addresses for recruitment purposes and does not conduct interviews via social media or other third-party sites. Please report any suspicious recruiting activity to us at careers@mightytx.com and to the Internet Crime Complaint Center.